Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Prostate. 2017 Feb 27;77(8):888–899. doi: 10.1002/pros.23343

Fig. 5. SR1001 or IL-17 antibody treatment decreases EMT in mouse prostate tumors.

Fig. 5

A-F: Representative prostate sections from SR1001 and DMSO-treated mice stained for EMT markers. Arrows indicate positive staining cells. H-M: Representative prostate sections from IL-17 antibody and control IgG-treated mice stained for EMT markers; arrows indicate positive staining cells. G and N: Quantification of EMT markers staining; Total Score (TS) = Proportion Score (PS, range 0 - 5) + Intensity Score (IS, rang 0 - 3); data are represented as mean ± s.e.m., n = 3 animals per group, *P < 0.05, **P < 0.01.